Acrp Ccra/ccrc Certification Exam Prep

Monitoring Report {Ans: A written report from the monitor to the sponsor after each site visit and/or other trial-related communication according to the sponsor's SOPs.}Dropout {Ans: A subject in a clinical trial who for any reason fails to continue in the trial until the last visit required of him/her by the study protocol.}What is the consideration for trial design of a CT? {Ans: Utilize qualified individuals (e.g. biostatistician, clinical pharmacologists, and physicians) to design protocol and CRFs, planning the analyses to analyzing and preparing interim and final trial reports.}Central Randomization {Ans: A randomization method used in multicenter trials to obtain the desired overall distribution across treatment arms.}What is the reason for 'Pharmacokinetics (PK) Study In phase 1 trials'? {Ans: Assess the clearance of the drug and to anticipate possible accumulation of parent drug or metabolites and potential drug-drug interactions.}Good Clinical Practice (GCP) {Ans: A standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials that provides assurance that the data and reported results are credible and accurate, and that the rights, integrity, and confidentiality of trial subjects are protected.}Unexpected Adverse Drug Reaction {Ans: An adverse reaction, the nature